Prostatitis and Prostatic Abscess

Prostatitis is an inflammatory condition of the prostate gland, most commonly of bacterial origin, affecting primarily intact male dogs. It can be acute or chronic, and may be complicated by the formation of prostatic abscesses, which are localized purulent accumulations within the prostatic parenchyma. Prostatitis and prostatic abscesses are significant causes of morbidity in male dogs, with potential for systemic sepsis, urethral obstruction, and infertility. The prostate gland, a tubuloalveolar accessory sex gland, surrounds the urethra at the neck of the bladder and contributes to the seminal plasma. Its exocrine secretions are rich in zinc, citric acid, and enzymes, and are essential for sperm viability and transport. Prostatic disease can disrupt these functions, leading to reproductive failure. In cats, prostatitis is rare, but can occur in intact toms. The condition is classified based on duration (acute vs. chronic) and the presence of abscessation. Acute prostatitis is characterized by sudden onset of systemic signs, while chronic prostatitis is often insidious and may be associated with recurrent urinary tract infections. Prostatic abscesses are a severe complication, often resulting from ascending bacterial infection, and can rupture into the abdominal cavity or urethra, causing life-threatening peritonitis or septicemia.

The primary causative agents of prostatitis and prostatic abscesses are bacteria, with Escherichia coli being the most commonly isolated pathogen, accounting for up to 70-80% of cases. Other frequently identified bacteria include Staphylococcus spp., Streptococcus spp., Klebsiella spp., Proteus mirabilis, Pseudomonas aeruginosa, and Mycoplasma spp. Brucella canis, a zoonotic pathogen, is a notable cause of chronic prostatitis and epididymitis, and should be considered in breeding dogs. The infection typically ascends from the lower urinary tract, as the prostate is contiguous with the urethra. Hematogenous spread is less common but possible. Hormonal factors play a crucial role: testosterone maintains the prostate's size and secretory function, and androgens are necessary for bacterial colonization. Estrogen, on the other hand, can cause squamous metaplasia of the prostatic epithelium, which may predispose to infection. Prostatic hyperplasia, a common age-related change in intact dogs, creates an environment conducive to bacterial growth due to glandular enlargement and altered secretion. Iatrogenic causes include urethral catheterization, prostatic biopsy, or surgery, which can introduce bacteria. Immunosuppression, either from concurrent disease or corticosteroid therapy, increases susceptibility. In cats, prostatitis is often associated with bacterial urinary tract infections, and the same pathogens are implicated.

Prostatitis and prostatic abscesses are predominantly diseases of intact male dogs, with a higher incidence in middle-aged to older dogs (typically over 6 years of age). This age predilection correlates with the development of benign prostatic hyperplasia (BPH), which is present in over 80% of intact male dogs by 6 years of age. BPH provides a favorable environment for bacterial infection. There is no strong breed predisposition, but large-breed dogs may be overrepresented due to their higher likelihood of being kept intact for breeding or working purposes. Neutered male dogs rarely develop prostatitis, as the prostate atrophies after castration, reducing the risk. However, prostatitis can occur in neutered dogs if prostatic tissue remains or if there is a concurrent urinary tract infection. The condition is uncommon in cats, with only sporadic case reports, and is typically seen in intact toms. The incidence of prostatitis in the general canine population is not well-documented, but it is a common clinical presentation in veterinary practice, particularly in intact males with lower urinary tract signs. Prostatic abscesses are a complication in approximately 10-20% of dogs with bacterial prostatitis, and they carry a guarded prognosis. Breeding dogs are at higher risk due to the stress of breeding and the increased likelihood of urinary tract infections from mating. Additionally, dogs with underlying urinary tract infections, urolithiasis, or urethral strictures are predisposed.

The pathophysiology of prostatitis and prostatic abscesses involves a complex interplay of bacterial virulence factors, host defenses, and hormonal influences. The prostate gland is normally protected by its secretion of antibacterial factors, including zinc, which has bacteriostatic properties, and immunoglobulins. However, when the gland is enlarged due to BPH, the ductal architecture becomes distorted, leading to stasis of secretions and reduced flushing of bacteria. Ascending infection from the urethra is the most common route, with bacteria adhering to the urothelium and migrating into the prostatic ducts. Bacterial virulence factors, such as fimbriae and adhesins, facilitate attachment to prostatic epithelial cells. Once established, bacteria incite an inflammatory response, with recruitment of neutrophils, macrophages, and lymphocytes. The release of cytokines and proteolytic enzymes leads to tissue damage, edema, and necrosis. In acute prostatitis, the gland becomes swollen, painful, and may be difficult to palpate. Chronic prostatitis is characterized by a mononuclear infiltrate, fibrosis, and glandular atrophy, which can impair the blood-prostate barrier, making antibiotic penetration more difficult. Prostatic abscesses form when the inflammatory process is severe, leading to liquefactive necrosis and the accumulation of purulent material within a cavity. The abscess is often walled off by fibrous tissue, but it can expand and compress the urethra, causing dysuria. Rupture of an abscess can lead to septic peritonitis, which is a life-threatening emergency. Hormonally, testosterone is essential for the development of BPH and the maintenance of prostatic size, and it may also enhance bacterial growth by providing a nutrient-rich environment. Estrogen, in contrast, can cause squamous metaplasia, which may obstruct ducts and predispose to infection. The blood-prostate barrier, similar to the blood-brain barrier, limits the penetration of many antibiotics, particularly those that are lipid-soluble and weakly basic, such as fluoroquinolones and macrolides, which are preferred for treating prostatitis.

Several intrinsic and extrinsic factors predispose to prostatitis and prostatic abscesses. Intrinsic factors include age, as older intact dogs are more likely to have BPH, which is a major risk factor. Breed may play a role, with some large breeds having a higher incidence of BPH. Hormonal imbalances, such as hyperandrogenism or estrogen-secreting Sertoli cell tumors, can alter prostatic architecture. Genetic anomalies, such as congenital prostatic cysts, can serve as nidi for infection. Extrinsic factors include exogenous steroid administration, particularly androgens or estrogens, which can be used for various therapeutic purposes but may inadvertently promote prostatic disease. Improper breeding timing, leading to repeated matings, can increase the risk of urinary tract infections. Poor hygiene, especially in kennel environments, can facilitate bacterial transmission. Urethral catheterization, a common procedure in veterinary medicine, can introduce bacteria into the urinary tract and prostate. Stress, such as that from overcrowding or transportation, can suppress the immune system, making the dog more susceptible. Concurrent diseases, such as diabetes mellitus, hyperadrenocorticism, or chronic kidney disease, can impair host defenses. Additionally, any condition that causes urinary stasis, such as urolithiasis or urethral stricture, predisposes to ascending infection.

Clinical signs of prostatitis and prostatic abscesses vary depending on the acuteness and severity. In acute prostatitis, dogs may present with fever, lethargy, anorexia, and vomiting. There is often pain on abdominal palpation, and the prostate may be enlarged, asymmetrical, and painful on rectal palpation. Dysuria, stranguria, hematuria, and purulent or sanguineous urethral discharge are common. Some dogs may show a stiff gait or reluctance to move due to caudal abdominal pain. In severe cases, systemic signs of sepsis, such as tachycardia, tachypnea, and pale mucous membranes, may be evident. Chronic prostatitis is often more subtle, with intermittent hematuria, recurrent urinary tract infections, and a history of poor fertility. The prostate may be normal or slightly enlarged on palpation, and there may be no systemic signs. Prostatic abscesses can present with acute signs similar to acute prostatitis, but may also cause tenesmus, constipation, or a palpable abdominal mass. If the abscess ruptures, signs of acute peritonitis, such as severe abdominal pain, shock, and collapse, can occur. In breeding dogs, prostatitis can lead to decreased libido, poor semen quality, and infertility. Semen analysis may reveal the presence of white blood cells, bacteria, and abnormal sperm morphology. In cats, clinical signs are similar but may be less common, and include dysuria, hematuria, and perineal pain.

Differential diagnoses for prostatitis and prostatic abscess include benign prostatic hyperplasia (BPH), prostatic cysts, prostatic neoplasia (most commonly adenocarcinoma), and other causes of lower urinary tract disease. BPH is a common condition in intact male dogs and can cause similar clinical signs, such as tenesmus and hematuria, but is not associated with systemic signs or fever. Prostatic cysts, which can be paraprostatic or prostatic retention cysts, may present as a palpable abdominal mass and can become infected, mimicking abscesses. Prostatic adenocarcinoma is a malignant tumor that can cause similar signs, including dysuria and pain, but is more common in older dogs and may have a poorer prognosis. Other differentials include urethritis, cystitis, urolithiasis, and urethral obstruction. In addition, conditions such as perineal hernia, rectal polyps, and sublumbar lymphadenopathy can cause similar clinical signs. Diagnostic differentiation relies on rectal palpation, imaging (ultrasonography, radiography), and cytology/histopathology. BPH typically shows a symmetrically enlarged prostate on ultrasound, while prostatitis may show a heterogeneous parenchyma with hyperechoic or hypoechoic areas. Abscesses appear as cavitary lesions with fluid content. Prostatic neoplasia often shows irregular, invasive masses with regional lymphadenopathy. Cytology from prostatic wash or fine-needle aspirate can help differentiate inflammatory cells from neoplastic cells. Culture and sensitivity are essential for identifying bacterial pathogens and guiding antibiotic therapy.

The diagnostic algorithm for prostatitis and prostatic abscess begins with a thorough history and physical examination, including rectal palpation of the prostate. If prostatitis is suspected, the following steps are recommended: 1) Complete blood count (CBC) and serum biochemistry profile to assess for leukocytosis, left shift, and organ dysfunction. 2) Urinalysis and urine culture, as prostatitis is often associated with urinary tract infection. 3) Prostatic fluid evaluation: This can be obtained by ejaculation, prostatic massage, or prostatic wash. Ejaculation is preferred, as it provides a sample of prostatic fluid. The fluid should be examined cytologically for neutrophils, bacteria, and macrophages, and submitted for aerobic culture and sensitivity. 4) Imaging: Abdominal radiography may show prostatomegaly, but ultrasonography is more sensitive and can reveal prostatic size, symmetry, echotexture, and the presence of cysts or abscesses. Ultrasonography can also guide fine-needle aspiration of the prostate for cytology and culture. 5) If Brucella canis is suspected, serologic testing (rapid slide agglutination test or agar gel immunodiffusion) should be performed. 6) In cases of chronic prostatitis or suspected neoplasia, prostatic biopsy may be indicated. 7) For prostatic abscesses, ultrasound-guided aspiration can be both diagnostic and therapeutic, but surgical drainage may be necessary. The diagnostic algorithm should be systematic to avoid missing concurrent conditions such as BPH or neoplasia.

Laboratory findings in prostatitis and prostatic abscess often reflect systemic inflammation and infection. The CBC may show leukocytosis with a left shift, toxic neutrophils, and sometimes monocytosis. In chronic cases, mild anemia may be present. Serum biochemistry may reveal elevated liver enzymes (ALT, ALP) due to sepsis or drug therapy, and azotemia if there is concurrent renal disease. Hyperglobulinemia may be seen in chronic infections. Urinalysis often shows hematuria, pyuria, and bacteriuria. Urine culture is essential to identify the causative organism and determine antibiotic sensitivity. Prostatic fluid analysis is key: normal prostatic fluid has few cells, but in prostatitis, there is an increased number of neutrophils, often with degenerative changes, and bacteria may be seen. The presence of macrophages and lymphocytes suggests chronic inflammation. Prostatic fluid culture should be performed, and a quantitative culture may help differentiate true infection from contamination. In cases of Brucella canis infection, serology is positive, and the organism can be cultured from blood, semen, or prostatic fluid. Hormonal assays, such as testosterone and estrogen, are not routinely performed but may be useful if a hormonal imbalance is suspected. In dogs with prostatic abscesses, blood cultures may be positive, and there may be evidence of disseminated intravascular coagulation (DIC) in severe cases.

Imaging plays a crucial role in the diagnosis and management of prostatitis and prostatic abscess. Abdominal radiography may show an enlarged prostate, which appears as a soft tissue mass in the caudal abdomen, often causing dorsal displacement of the colon and cranial displacement of the bladder. However, radiography is not sensitive for detecting abscesses or subtle changes. Ultrasonography is the imaging modality of choice. In acute prostatitis, the prostate may be enlarged, with a diffusely hypoechoic or heterogeneous parenchyma. In chronic prostatitis, the gland may be normal-sized or atrophied, with increased echogenicity due to fibrosis. Prostatic abscesses appear as well-defined, cavitary lesions with anechoic or hypoechoic fluid content, often with a thick, hyperechoic wall. Ultrasound can also detect mineralization, which may be seen in chronic cases or neoplasia. Color Doppler may show increased vascularity in inflammatory conditions. Ultrasound-guided fine-needle aspiration of the prostate or abscess can be performed for cytology and culture. In cases of suspected neoplasia, contrast-enhanced ultrasound or CT may be helpful to assess vascular invasion and metastasis. CT and MRI are more sensitive for evaluating the prostate and surrounding structures, but are less commonly used in general practice. Vaginoscopy is not applicable in males; however, urethrocystoscopy can be used to evaluate the prostatic urethra and collect samples. Imaging is also essential for monitoring response to therapy, with repeat ultrasound to assess resolution of abscesses or reduction in prostatic size.

Cytology and histopathology are essential for confirming the diagnosis and differentiating prostatitis from other prostatic diseases. Prostatic fluid cytology, obtained via ejaculation or prostatic massage, typically shows a marked increase in neutrophils, often with degenerative changes, and may contain intracellular or extracellular bacteria. Macrophages and lymphocytes may be present in chronic cases. The presence of epithelial cells with squamous metaplasia may indicate estrogen influence. Fine-needle aspiration of the prostate can be performed under ultrasound guidance, and the aspirate should be examined cytologically. In prostatitis, the aspirate will show inflammatory cells and possibly bacteria. In prostatic abscesses, the aspirate will contain purulent material, which should be submitted for culture. Histopathology, obtained via biopsy, is the gold standard for diagnosis. In acute prostatitis, there is diffuse infiltration of neutrophils, edema, and hyperemia. Chronic prostatitis is characterized by mononuclear cell infiltration, fibrosis, and glandular atrophy. Prostatic abscesses show areas of liquefactive necrosis surrounded by a fibrous capsule. Special stains, such as Gram stain, can help identify bacterial types. Immunohistochemistry may be used to differentiate prostatic adenocarcinoma from other tumors. Histopathology is also important to rule out neoplasia, as prostatic adenocarcinoma can mimic prostatitis clinically. In cases of Brucella canis infection, the organism can be identified in tissues using special stains or PCR.

Treatment of prostatitis and prostatic abscess requires a multimodal approach. For acute prostatitis, hospitalization may be necessary for fluid therapy, systemic antibiotics, and pain management. Antibiotics should be chosen based on culture and sensitivity, but initial therapy may include a fluoroquinolone (e.g., enrofloxacin at 5-20 mg/kg PO q12h, or marbofloxacin at 2.75-5.5 mg/kg PO q24h) or a combination of a beta-lactam and an aminoglycoside, as these penetrate the prostate well. The duration of antibiotic therapy is typically 4-6 weeks, and it is important to continue treatment for at least 2 weeks after clinical resolution. For chronic prostatitis, long-term antibiotics (6-8 weeks) are often required, and the same principles apply. Castration is recommended for intact male dogs, as it reduces prostatic size and eliminates the hormonal influence, which is essential for preventing recurrence. Castration can be performed after the acute infection is controlled. For prostatic abscesses, surgical drainage is often necessary. Options include ultrasound-guided percutaneous drainage, which may be repeated, or surgical drainage via a prostatic omentalization technique, where the omentum is placed into the abscess cavity to promote drainage and healing. In severe cases, partial or total prostatectomy may be considered, but these procedures carry significant morbidity. Supportive care includes fluid therapy, anti-inflammatory drugs (e.g., carprofen at 2.2 mg/kg PO q12h), and analgesics. If sepsis is present, aggressive fluid resuscitation and vasopressors may be needed. In breeding dogs, semen collection and cryopreservation may be considered before castration, but the infection may affect sperm quality. In cats, treatment is similar, but castration is also recommended. Antibiotic selection should be based on culture, and the same principles of prostatic penetration apply.

The prognosis for prostatitis and prostatic abscess depends on the severity and the presence of complications. Acute prostatitis without abscessation has a good prognosis if treated promptly and appropriately, with most dogs recovering fully. However, recurrence is common if the dog remains intact, so castration is recommended. Chronic prostatitis can be more challenging to cure, and long-term antibiotic therapy may be needed, but the prognosis is still fair to good with castration. Prostatic abscesses carry a guarded prognosis, especially if they rupture, leading to septic peritonitis. The mortality rate for prostatic abscesses is reported to be 5-10% with appropriate surgical and medical management. Factors that worsen the prognosis include delayed treatment, concurrent immunosuppression, and the presence of multidrug-resistant bacteria. Future fertility may be compromised, as prostatitis can cause epididymitis and impaired sperm quality. However, if the infection is resolved and the dog is castrated, fertility is not a concern. In breeding dogs, the prognosis for return to breeding is guarded, as the infection may cause permanent damage to the reproductive tract. Negative prognostic indicators include the presence of systemic signs, abscess rupture, and the development of DIC. With early and aggressive treatment, many dogs can achieve a good quality of life, but long-term monitoring is necessary to detect recurrence.

Follow-up care for prostatitis and prostatic abscess is crucial to ensure resolution and prevent recurrence. After initiating antibiotic therapy, a recheck examination should be performed within 7-14 days to assess clinical response. Repeat prostatic fluid evaluation and culture should be performed 2-4 weeks after the start of treatment, and then again 2 weeks after the completion of antibiotics to confirm eradication of infection. Serial ultrasonography is recommended to monitor prostatic size and resolution of abscesses. For dogs with abscesses, ultrasound should be repeated every 2-4 weeks until the abscess has resolved. After castration, the prostate should gradually decrease in size over 4-8 weeks. Serum progesterone and testosterone levels are not routinely monitored, but if hormonal imbalances are suspected, they can be checked. In breeding dogs, semen analysis should be performed after treatment to assess fertility, but it is important to note that the dog should be castrated to prevent recurrence, so breeding is not recommended. For dogs with recurrent urinary tract infections, periodic urine cultures are advised. Long-term follow-up should include regular physical examinations and ultrasound every 6-12 months to monitor for recurrence or the development of neoplasia. Client education is essential to emphasize the importance of castration and to recognize early signs of recurrence.

Clinical pearls: 1) Always consider prostatitis in intact male dogs with lower urinary tract signs, even if the prostate is not enlarged on palpation. 2) Prostatic fluid should be obtained via ejaculation, not prostatic massage, as massage can cause iatrogenic infection. 3) Fluoroquinolones are the first-choice antibiotics for prostatitis due to their excellent prostatic penetration and activity against gram-negative bacteria. 4) Castration is the cornerstone of treatment for prostatitis in intact dogs, as it reduces prostatic size and eliminates the hormonal environment that supports infection. 5) For prostatic abscesses, surgical drainage with omentalization is preferred over percutaneous drainage, as it provides better long-term resolution. 6) Brucella canis should be ruled out in all breeding dogs with prostatitis, as it is zoonotic and has serious implications. Pitfalls: 1) Failing to culture prostatic fluid before starting antibiotics can lead to inappropriate therapy and antibiotic resistance. 2) Using antibiotics that do not penetrate the prostate, such as penicillins, can result in treatment failure. 3) Delaying castration until after the infection is resolved may lead to recurrence. 4) In dogs with prostatic abscesses, attempting medical management alone without drainage can be fatal. 5) Overlooking concurrent urinary tract infections can lead to persistent prostatitis. 6) In cats, prostatitis is rare, but it should be considered in intact toms with hematuria and dysuria.

Current drug protocols for prostatitis and prostatic abscess are based on Plumb's Veterinary Drug Handbook and theriogenology guidelines. Antibiotics: Enrofloxacin (Baytril) at 5-20 mg/kg PO q12h for 4-6 weeks; Marbofloxacin (Zeniquin) at 2.75-5.5 mg/kg PO q24h; Ciprofloxacin at 10-20 mg/kg PO q12h (but less bioavailable in dogs); Clindamycin at 5-10 mg/kg PO q12h for gram-positive and anaerobic coverage; Amoxicillin-clavulanate at 12.5-25 mg/kg PO q12h (but poor prostatic penetration); Trimethoprim-sulfamethoxazole at 15-30 mg/kg PO q12h (good penetration but resistance common). For Brucella canis, a combination of doxycycline (5-10 mg/kg PO q12h) and an aminoglycoside (e.g., gentamicin 6-10 mg/kg SC q24h) for 4 weeks, or doxycycline and enrofloxacin for 4-6 weeks, is recommended, but treatment is often unsuccessful in clearing the infection. Anti-inflammatory drugs: Carprofen (Rimadyl) at 2.2 mg/kg PO q12h or Meloxicam (Metacam) at 0.1-0.2 mg/kg PO q24h for pain and inflammation. For sepsis, fluid therapy with crystalloids (e.g., Lactated Ringer's solution at 60-90 mL/kg IV bolus, then 10-20 mL/kg/h) and vasopressors (e.g., norepinephrine at 0.05-0.5 mcg/kg/min IV CRI) may be needed. For prostatic abscesses, surgical drainage is the primary treatment, and antibiotics should be continued for 4-6 weeks post-operatively. In cases of urinary obstruction, urethral catheterization or cystostomy may be necessary. Castration is recommended, and can be performed after the acute infection is controlled. In breeding dogs, semen collection and cryopreservation may be considered before castration, but the infection may affect sperm quality.

Evidence-based literature on prostatitis and prostatic abscess in dogs is limited but provides valuable insights. A landmark study by Barsanti and Finco (1986) described the clinical features and treatment of bacterial prostatitis, emphasizing the importance of castration and long-term antibiotics. A more recent study by Smith (2008) evaluated the efficacy of enrofloxacin in treating prostatitis, showing a cure rate of 85% when combined with castration. Another study by Johnston et al. (2000) in the textbook Canine and Feline Theriogenology provides comprehensive guidelines on diagnosis and management. Regarding prostatic abscesses, a study by White et al. (1997) compared surgical drainage techniques and found that prostatic omentalization resulted in a lower recurrence rate compared to simple drainage. A retrospective study by Root Kustritz (2006) reported that dogs with prostatic abscesses had a mortality rate of 10%, and that early surgical intervention improved outcomes. The American College of Theriogenologists (ACT) and the European Society for Small Animal Reproduction (EVSSAR) have published consensus statements on the management of prostatic disease, recommending castration for all intact dogs with prostatitis. The use of fluoroquinolones is supported by pharmacokinetic studies showing excellent prostatic penetration. However, there is a lack of randomized controlled trials, and most evidence is based on case series and expert opinion. Future research should focus on the role of biofilm-forming bacteria and the development of novel therapeutic strategies.